The paid pumpers, lead by their latest comrade, Maxdad, are becoming more and more desperate. These guys, jagan, douyoulikeneruda, shortsareevil, jaybull and many others that come posting once or twice from their cubicles are paid by the MMs and their crony hedge/mutual funds who see the writing on the wall about AFFY's demise and are eager to dump their millions of AFFY shares onto retail longs before the shares become worthless when AFFY seeks protection under the bankruptcy laws. It is all part of what I describe as Operation Retail AFFY Bagholders.
Retail cannot short AFFY stock. There are no shares available to short. Retail can only buy AFFY stock in the hope that AFFY will rise from the dead or that the MMs will allow retail to sell later at a MM manipulated higher price to the greater fool so to speak. I have observed and posted on this board, for example, that the MMs took the price from $1.33 to $1.42 and then watched as a 1.1M share sale order immediately went through taking the price back to $1.30. I sarcastically said that it must have been some retail long taking profit right? My posts about AFFY's dire financial circumstances, and my posts about Omontys disastrous actual patient usage and dangerous safety profile as reported by legitimate brokerage analysts, news reporting, test results and physicians, are intended by me to educate retail longs about the true risks involved in "investing" in AFFY. My mantra has been if you can play the MM swings then go ahead, but do not make the mistake of buy and hold even short term because you will lose your money.
Since the paid pumpers cannot dispute my posts, which are often supported by quotes and citations to references, they have had to utilize ad hominem attacks instead. They label me with horrible names, deride my posts as "cut and paste" and "unoriginal". They challenge me to juvenile games and when I refuse to play they attack my credibility. They are desperate. Be advised. Thank you.
Listen idiot. With my background education and experience in life, I don't need to prove myself to anyone, and especially you. You are an absolute idiot to believe that anyone with a background such as mine has any need to play your juvenile game. Grow up.
I will not do so Maxdad. Your "test" as you say is a no win proposition for me. It is your "private test" and you can choose to have your way with whatever I may choose to do. I do not trust or respect you. So I refuse to play your nonsensical game, you "CHARLETAIN", to use your own epithet as you called me to describe you and your so-called test.
With that kind of background, you have nothing better to do. I am retired and have been since 2005. You are nothing more than a paid pumper idiot maxdad. The purpose of this message board is not to take your nonsensical test whatever it may be. You have gall I will admit that. As much hubris as the idiots who earlier demanded that I publish my trades. But maybe you work for the IRS. You seem familiar with their hounding, strong arm tactics. Like I earlier posted, I refuse to debate with idiots because they take you down to their level and then beat you with experience.
PS Maxdad, readers excuse typos but clearly misspelled words belie your stupidity, lack of education or your paid pumper status. You might want to check the actual spelling of what I thought you meant to call me when you typed "CHARLETAIN".
And of course, your own analyses are both perfect and much better than the RW Baird's analyst report I quoted that demonstrates just how dangerous O has proven itself to be in actual patient usage. Yep. You are the brilliant analyst who transformed AFFY's path to Chapter 11 bankruptcy reorganization to a billion dollar plus Royalties trust! You are so full of yourself that I find you completely amusing. Thank you for your idiotic posts. I truly enjoy reading them for their sheer lunacy.
JMHO that O's problems are more than a first day reaction issue. RW Baird analyst Christopher Raymond's published research notes: "[L]ooking at FDA’s advere event database for Epogen, Omontys appears to confer a 100-fold higher incidence of hypersensitivity and an 8.5-fold higher incidence of drug-related death (and that’s new). This analysis isn’t perfect, but we think the magnitude is such that there’s a clear signal here.” The clear signal, obviously, is that O is obviously unsafe compared to the established safety profile of the industry standard Epogen.
A good thought to end the trading week and face a three day weekend. Remember our veterans this memorial day.
While I am not a stock market professional and am just a regular day trader like many on YMB, I do have a nice six figure profit in my AFFY short position and am in no hurry to close my position.
O has been pending approval before the EMA since Feb/Mar 2012. Why a decision now after more than a year of pending approval? How is it great news and a "huge uptick for AFFY" should the EMA do nothing (most likely) so that O remains in the over one year's status on the list of EMA drugs pending approval? There is no chance of O being approved by the EMA while its status is withdrawn from the US market due to adverse patient reactions. With all the bad news about AFFY and O, the long pumpers grasp at straws to pump O as part of Operation AFFY Retail Bagholders.
The same kind of "voluntary" recall like the "voluntary" payment to AFFY's Lenders for the Loan that was in default. Also the fact is that O is in a recalled status before the FDA. No lies by me. Just facts. Now Maxdad says I am an "extremely gruntled ex-employee who would otherwise wish to confer violence on Affy..." As in Shakespeare's Hamlet, "The [Maxdad] doth protest too much, methinks." The truth must hurt his agenda as part of Operation AFFY Retail Bagholders.
O has been pending approval before the EMA since Feb/Mar 2012. Why a decision now after more than a year of pending approval? Now Jagan expects EMA approval for O next Monday. Last Friday, a week ago, Jagan posted that he "wouldn't be surprised" to wake up the next Monday to see the announcement of an AFFY buyout. What do you think this paid pumper's agenda is? All part of what I call Operation AFFY Retail Bagholders. Don't drink Jagan's Kool-aid.
I have a six figure profit in my AFFY short position. I guess you are saying I am on the wrong side of the AFFY trade? If anyone is interested, please check my posts. Napas is lying about my track recored.
When faced with the reality that AFFY has (1) terminated all its employees, (2) closed its offices, (3) scheduled the auction of all of its tangible property, (4) has no revenues (5) disclosed liabilities exceed assets, (6) disclosed approx $5M "free" cash as of March 31, (7) disclosed pending securities class actions (8) disclosed pending shareholder derivitave actions (9) disclosed that it anticipates products liability claims to be filed, (10) disclosed that its insurance may be denied or prove inadequate to cover litigaion expenses and liabilities and (11) disclosed that it has hired The Brenner Group, whose primary specialty is guiding technology companies through Chapter 11 reorganization, what is a long pumper to do?
I'll tell you what the long pumpers do in this situation: (1) deny reality, (2) call the wind down of operations leading toward Chapter 11 reorganization, the transformation of AFFY to a ROYALTY TRUST. Bottom line: AFFY long pumpers put lipstick on the AFFY bankrupt pig as part of Operation AFFY Retail Bagholders.
IMHO it would be against legal advice for Takeda to withdraw the O EMA application which has been pending approval since Feb/Mar 2012. Should Takeda do that, it could be construed as plaintiff's attorneys in both the securities class action litigations and the expected products liability litigations as an admission that O is defective. It is better, from a legal liability standpoint, for Takeda not to act on its own concerning the O EMA application. As long as the drug remains on recalled status before the FDA, there is no chance for EMA approval however.
Virtually worthless is my prediction. Is that zero? Certainly less than 50 cents. Maybe 18 cents or even less?
It is not like that characterization at all. It is like a failed drug and a company going bankrupt.
Everybody seems to be betting on the favorite: AFFY Chapter 11 reorganization. Seems like a sure winner for AFFY stock to go virtually worthless.
If so josebell639, you are either one of the legion of paid pumpers, a fool, or both. I cannot see any other alternative. I am guessing here, but maybe you are in the market for the snake oil Max touts.